AXT's 162% Q3 revenue jump and $500 million-plus backlog point to booming InP demand. Yet its 191% rally and valuation premium raise the stakes for investors.
AXT's 162% Q3 revenue jump and $500 million-plus backlog point to booming InP demand. Yet its 191% rally and valuation premium raise the stakes for investors.
FormFactor shares plunge nearly 12% after Q3 earnings as weak Q4 guidance and capacity constraints weigh on sentiment. Can AI demand and expansion fuel a rebound?
Five stocks, including Healthcare Services Group and CarMax, stand out for superior efficiency ratios and strong earnings surprises, offering compelling growth potential.